Skip to main content
IRS-authorized e-file provider · not the IRS

Nonprofit · EIN 84-2240648

CURESHANK

Tax-exempt · LOS ANGELES, CA 90049

Financials

$465K$288K2023$598K$528K2024
Revenue Expenses · by fiscal year end
Financials of CURESHANK by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$597,811$528,155$69,656$1,118,841$7,162$1,111,679
December 31, 2023990$464,972$287,968$177,004$1,042,385$362$1,042,023
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$586,766
Program service revenue
$0
Investment income
$11,045
Other revenue
$0

Expenses

Grants and similar amounts paid
$83,728
Compensation of officers, directors and key employees
$0
Salaries, compensation and benefits (total)
$0
Professional fundraising fees
$0
Legal fees
$32,448
Accounting fees
$10,789
Program services (functional)
$456,770
Management and general (functional)
$37,412
Fundraising (functional)
$33,973

Balance sheet and other

Total assets, start of year
$1,042,385
Total assets, end of year
$1,118,841
Total liabilities, end of year
$7,162
Net assets, end of year
$1,111,679
Land, buildings and equipment
$5,886
Publicly traded securities
$24,541
Net assets without donor restrictions
$1,111,679
Gross receipts
$597,811
Employees
0
Volunteers
7
Year formed
2019
State of legal domicile
CA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
Geraldine BlissPresident
Trustee or director, Officer
50$0
Talya Emery SilvaVice President
Trustee or director, Officer
50$0
Abby LievenseTreasurer
Trustee or director, Officer
20$0
Laura HinrichsenSecretary
Trustee or director, Officer
10$0
Grace LiDirector
Trustee or director
10$0
Jenny Graham BeesonDirector
Trustee or director
10$0
Laura HinrichsenDirector
Trustee or director
10$0
Paulina RychenkovaDirector
Trustee or director
5$0
990 for the year ended December 31, 2023: 4 people
NameTitleHours / weekCompensation
GERALDINE BLISSPRESIDENT
Trustee or director, Officer
50$0
PAULINA RYCHENKOVASECRETARY
Trustee or director, Officer
5$0
ABBY LIEVENSETREASURER
Trustee or director, Officer
15$0
TALYA EMERY SILVAVICE PRESIDENT
Trustee or director, Officer
35$0

Address and contacts

Address (IRS master file)
11777 SAN VICENTE BLVD STE 500, LOS ANGELES, CA 90049-5050
In care of
% GERALDINE BLISS
Principal officer (990 for 2024)
Abby Lievense, 11777 San Vicente Blvd 500, Los Angeles, CA 90049
Signed the 990
Abby Lievense, Treasurer
Phone
(310) 409-8060
Return prepared by
JACOBSON LAWRENCE & ASSOCIATES PLLC

California records

California keeps its own records of charities and corporations. Search them by EIN 84-2240648 or by the name CURESHANK.

Attorney General, Registry of Charities and Fundraisers
Registration status and filed reports (CT-TR-1, RRF-1)

Mission

CureSHANK has a singular purpose: To accelerate the development of treatments for Phelan-McDermid Syndrome and SHANK-related disorders. Our approach is to identify and fund projects that overcome critical barriers to successful drug development and to coordinate scientific efforts to improve efficiency and speed in the field.

990 for the year ended December 31, 2024

Program accomplishments

  • CureSHANK will bring the scientific community together by organizing scientific symposium and other meetings. With our scientific stakeholders, we will develop a research roadmap to a cure for SHANK-related disorders. We will also serve as an honest broker to enable collaboration among SHANK researchers and coordination of their projects to improve the speed and efficiency of research.
    Expenses $279,862 · grants $83,728
  • CureSHANK will fund targeted research studies, including scientific projects that elucidate the underlying disease mechanisms, that identify and validate targets for drug development, and that de-risk promising drug targets. CureSHANK will also fund certain promising clinical trials readiness initiatives. These activities are needed to increase the number of drug targets moving from academic research labs into successful industry-sponsored clinical trials.
    Expenses $131,845
  • CureSHANK will advocate for increased funding of SHANK research by other stakeholders and strategize with researchers on initiatives, such as seed grants, that could help attract research investment by other funders.
    Expenses $45,063

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
84-2240648
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2020
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H84)
Assets (IRS master file)
$1,118,841
Income (IRS master file)
$597,811

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$597,811$528,155$1,118,841XML
990December 2023$464,972$287,968$1,042,385XML
990December 2022$487,302$219,660$854,048IRS
990December 2021–––IRS
990-EZDecember 2020–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 84-2240648).

Questions about CURESHANK

What is the EIN of CURESHANK?
The employer identification number (EIN) of CURESHANK is 84-2240648.
Is CURESHANK tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2020.
Are donations to CURESHANK tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does CURESHANK file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of CURESHANK due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did CURESHANK last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of CURESHANK?
The 990 for the year ended December 31, 2024 names Abby Lievense.
Who are the officers and directors of CURESHANK?
The 990 for the year ended December 31, 2024 lists 8 people; 0 received compensation from the organization.
How much revenue does CURESHANK have?
On its 990 for the year ended December 31, 2024 it reported revenue of $597,811, expenses of $528,155 and total assets of $1,118,841 at year end.

Other nonprofits in LOS ANGELES

All nonprofits in LOS ANGELES · California · Medical research